Symptomtext
products been administered post excursion with no reported adverse event; Initial information received on 08-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 51 years old female patient who has been administered Diphtheria-2/Tetanus/5 AC Pertussis vaccine [ADACEL] post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Diphtheria-2/TETANUS/5 AC Pertussis vaccine Suspension for injection of lot U7929AA and expiry: 14-Nov-2025 via unknown route in unknown administration site for immunization. On an unknown date, the patient has been administered Diphtheria-2/Tetanus/5 AC Pertussis vaccine post excursion with no reported adverse event (poor quality product administered) (latency: same day). No lab data was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA353755:01836321, 01836324 US-SA-2023SA353804:01836321